 PLYMOUTH MEETING, Pa., May 26, 2021 PRNewswire -- Harmony Biosciences Holdings, Inc. Harmony Nasdaq: HRMY, a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients living with rare neurological disorders who have unmet medical needs, today announced that Harmonys President and CEO, John Jacobs, will participate in fireside chats and host investor meetings at the following upcoming virtual conferences: Jefferies Healthcare ConferenceFireside Chat: June 2, 2:30pm ET Goldman Sachs 42nd Annual Global Healthcare ConferenceFireside Chat: June 10, 3:50pm ET Raymond James Human Health Innovation ConferenceFireside Chat: June 21, 3:20pm ET The live audio webcast of the fireside chats will be available on the investor page of Harmonys website at 